Theoretical and molecular mechanistic investigations of novel (3-(furan-2-yl)pyrazol-4-yl) chalcones against lung carcinoma cell line (A549).

MLA

Mohamed, Magda F., et al. “Theoretical and Molecular Mechanistic Investigations of Novel (3-(Furan-2-Yl)Pyrazol-4-Yl) Chalcones against Lung Carcinoma Cell Line (A549).” Naunyn-Schmiedeberg’s Archives of Pharmacology, vol. 396, no. 4, Apr. 2023, pp. 719–36. EBSCOhost, https://doi.org/10.1007/s00210-022-02344-x.

APA

Mohamed, M. F., Ibrahim, N. S., Saddiq, A. A., Almaghrabi, O. A., Al-Hazemi, M. E., Hassaneen, H. M., & Abdelhamid, I. A. (2023). Theoretical and molecular mechanistic investigations of novel (3-(furan-2-yl)pyrazol-4-yl) chalcones against lung carcinoma cell line (A549). Naunyn-Schmiedeberg’s Archives of Pharmacology, 396(4), 719–736. https://doi.org/10.1007/s00210-022-02344-x

Chicago

Mohamed, Magda F., Nada S. Ibrahim, Amna A. Saddiq, Omar A. Almaghrabi, Maha E. Al-Hazemi, Hamdi M. Hassaneen, and Ismail A. Abdelhamid. 2023. “Theoretical and Molecular Mechanistic Investigations of Novel (3-(Furan-2-Yl)Pyrazol-4-Yl) Chalcones against Lung Carcinoma Cell Line (A549).” Naunyn-Schmiedeberg’s Archives of Pharmacology 396 (4): 719–36. doi:10.1007/s00210-022-02344-x.